PEOPLE - Q-MED makes appointment:
This article was originally published in Clinica
Executive Summary
The medical implants producer Q-MED based in Uppsala, Sweden, has appointed Mark van Rossum as sales director of its UK hospital healthcare division. Q-MED gel implants are based on the company's patented non-animal stabilised hyaluronic acid technology (NASHA) and are targeted at treatment of osteoarthritis of the knee and hip joints; female urinary incontinence; and vesicoureteral reflux in children.